Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

This study has been completed.
Sponsor:
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00055120
First received: February 19, 2003
Last updated: October 14, 2014
Last verified: October 2014